Physician profile
Jane Ogunsede
NPI 1518441641
$1,414.12
in general payments reported to CMS, 2019-2025
18 companies · $120 in 2025
The $120 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $70.51 · 2022: $236 · 2023: $518 · 2024: $470 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,108.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,107.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $375.00 | 2021-2024 | Proclaim, Eterna |
| Novo Nordisk INC | $249.96 | 2022-2023 | Wegovy |
| Nalu Medical, INC. | $159.00 | 2024 | Nalu Neurostimulation System |
| Phathom Pharmaceuticals, INC. | $120.16 | 2025 | Voquezna |
| Collegium Pharmaceutical, INC. | $113.53 | 2022-2024 | Xtampza |
| Relievant Medsystems, INC. | $94.92 | 2023 | Intracept |
| Pfizer INC. | $63.59 | 2023-2024 | |
| Janssen Pharmaceuticals, INC | $44.40 | 2024 | Spravato |
| Biohaven Pharmaceutical Holding Company LTD. | $43.85 | 2022 | |
| Amneal Pharmaceuticals LLC | $30.21 | 2023 | Lyvispah |
| Medtronic, INC. | $19.90 | 2022 | |
| Abbvie INC. | $19.73 | 2021 | |
| Scilex Pharmaceuticals INC. | $19.72 | 2022 | |
| Averitas Pharma INC. | $16.41 | 2024 | Qutenza |
| Arbor Pharmaceuticals, INC. | $14.85 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.68 | 2022 | |
| Horizon Therapeutics Plc | $11.21 | 2021 | |
| Spr Therapeutics, INC | $3.00 | 2023 | Sprint Pns System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jane Ogunsede listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.